ProShare Advisors
ORIC icon

ProShare Advisors’s Oric Pharmaceuticals ORIC Stock Holding History

ProShare Advisors’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$175K Sell
12,978
-200
-2% -$2.49K ﹤0.01% 1594
2026
Q2 		$143K Sell
13,178
-901
-6% -$8.17K ﹤0.01% 1725
2026
Q1 		$178K Sell
14,079
-2,313
-14% -$26.3K ﹤0.01% 1617
2025
Q4 		$134K Buy
16,392
+3,009
+22% +$34.6K ﹤0.01% 1816
2025
Q3 		$161K Buy
13,383
+1,527
+13% +$16.1K ﹤0.01% 1751
2025
Q2 		$120K Sell
11,856
-4,675
-28% -$31.4K ﹤0.01% 1841
2025
Q1 		$92.2K Sell
16,531
-4,152
-20% -$36.3K ﹤0.01% 1850
2024
Q4 		$167K Buy
20,683
+4,881
+31% +$44.8K ﹤0.01% 1940
2024
Q3 		$162K Buy
+15,802
New +$156K ﹤0.01% 1783
2024
Q2 		– Sell
-11,733
Closed -$161K – 1957
2024
Q1 		$161K Buy
+11,733
New +$139K ﹤0.01% 1725
2022
Q1 		– Sell
-12,447
Closed -$184K – 2273
2021
Q4 		$184K Sell
12,447
-2
-0% -$31 ﹤0.01% 2065
2021
Q3 		$260K Sell
12,449
-1,869
-13% -$37.9K ﹤0.01% 1647
2021
Q2 		$253K Buy
14,318
+3,187
+29% +$69.8K ﹤0.01% 2000
2021
Q1 		$273K Buy
11,131
+562
+5% +$17.8K ﹤0.01% 1858
2020
Q4 		$358K Buy
+10,569
New +$303K ﹤0.01% 1494

Other funds holding ORIC

Tema ETFs
Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Profund Advisors
Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return
China Universal Asset Management Company
China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $146M AUM 39.94% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $57B AUM 43.56% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return
Caitong International Asset Management
Caitong International Asset Management Hong Kong $1.04B AUM 150.25% 1-Year Est. Return

ProShare Advisors's ORIC Position: Q3 2026 in Review

ProShare Advisors reduced its Oric Pharmaceuticals (ORIC) stake by 1.5% in Q3 2026, selling an estimated $2.49K and leaving 12,978 shares worth $175K. The position accounts for ﹤0.01% of the portfolio, ranked #1594.

ProShare Advisors first reported a position in ORIC in Q4 2020 and has held it in 15 quarters since. The position peaked at $358K in Q4 2020. 27 funds tracked by Wall St. Rank hold ORIC as of Q3 2026.

  • ProShare Advisors held 12,978 shares of Oric Pharmaceuticals worth $175K as of Q3 2026.
  • ProShare Advisors sold 200 Oric Pharmaceuticals shares in Q3 2026, an estimated $2.49K.
  • Oric Pharmaceuticals made up ﹤0.01% of ProShare Advisors's portfolio in Q3 2026, its #1594 holding.
  • ProShare Advisors first reported a position in Oric Pharmaceuticals in Q4 2020 and has held it in 15 quarters since.
  • ProShare Advisors's Oric Pharmaceuticals position peaked at $358K in Q4 2020.
  • 27 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q3 2026.

Based on ProShare Advisors's 13F filing for Q3 2026, filed 29 Oct 2026.